Estimated read time: 2-3 minutes
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
[STK]
[IN] HEA MTC SPM BIO
[SU] ASI TDS
-- WITH PHOTO -- TO BUSINESS EDITORS:
Kibow Biotech Marks World Kidney Day with Introduction of RenadylT
Product to India Market
NEWTOWN SQUARE, Pa., March 13, 2014 /PRNewswire/ -- Kibow Biotech is
pleased to announce that it will mark World Kidney Day (March 13,
worldkidneyday.org) with the launch of RenadylT, its patented,
clinically validated probiotic dietary supplement for kidney health,
in India. This milestone event will coincide with Kibow's
participation as a NuFFoods probiotics sponsor at the 9th Nutra India
Summit, March 12-14, 2014 in Bangalore, India
(www.nutraindiasummit.in).
Photo - http://photos.prnewswire.com/prnh/20140313/PH82245LOGO-a
Photo - http://photos.prnewswire.com/prnh/20140313/PH82245LOGO-b
The product launch will take place on March 13th, during a dinner gala
at Le Meridien Hotel in Bangalore. This event represents a major
turning point for Kibow Biotech, whose primary goal is to help improve
the quality of life for kidney disease patients worldwide by
complementing their standard-of-care therapy with probiotic dietary
supplementation. Of particular interest to Kibow Biotech are the
patients in underdeveloped and developing countries, where access to
the commonly accepted treatment modalities of dialysis and
transplantation, both highly invasive and costly, is severely limited.
Throughout 16 years of continuous R&D, Kibow Biotech's team has been
privileged to provide support to kidney disease patients worldwide in
their struggle with chronic kidney failure. Kibow remains passionate
about patient health and continues to focus its research efforts on
developing new dietary supplement formulations that can provide
additional health benefits, specifically, an improved quality of life
for consumers worldwide.
About Kibow Biotech: Founded Oct 1, 1997 in Philadelphia, Kibow
Biotech specializes in research, development and commercialization of
probiotic dietary supplements adhering to US FDA and FTC regulations.
The Company's primary mission is to offer affordable, readily
available and easily administered dietary supplements in support of
kidney health and other healthcare applications. The Company's
flagship product, RenadylT, is currently marketed in the U.S. and
Canada, and will progressively be made available worldwide, according
to individual countries' governmental rules and regulatory
authorities.
For further information, contact:
Natarajan Ranganathan, PhD Managing Director 1 (610) 353-5130
Read more news from Kibow Biotech Inc.
SOURCE Kibow Biotech, Inc.
-0- 03/13/2014
/Photo: http://photos.prnewswire.com/prnh/20140313/PH82245LOGO-a
http://photos.prnewswire.com/prnh/20140313/PH82245LOGO-b
PRN Photo Desk, photodesk@prnewswire.com
CO: Kibow Biotech, Inc.
ST: Pennsylvania
IN: HEA MTC SPM BIO
SU: ASI TDS
PRN
-- PH82245 --
0000 03/13/2014 12:35:00 EDT http://www.prnewswire.com
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
